12/5/16 16:07 | 12/1/16 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | M.d | 64 | 2.55 | 8 | 25 | | 0 | D | | -17 | 38 | 9 | 11 | -15 | -11 | -2 | -6 | -12 | -20 | -35 | | |
12/5/16 16:07 | 12/1/16 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | S.d | -439 | 17.54 | 8 | -25 | -98 | 0 | D | | -17 | 38 | 9 | 11 | -15 | -11 | -2 | -6 | -12 | -20 | -35 | | |
6/6/16 16:06 | 6/2/16 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | M.d | 64 | 2.55 | 3 | 25 | | 0 | D | | -49 | -44 | 23 | 13 | 45 | 20 | 12 | -4 | -5 | 1 | 30 | 26 | |
6/6/16 16:06 | 6/2/16 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | S.d | -325 | 13.00 | 3 | -25 | -99 | 0 | D | | -49 | -44 | 23 | 13 | 45 | 20 | 12 | -4 | -5 | 1 | 30 | 26 | |
1/6/16 16:20 | 1/4/16 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | M.d | 89 | 2.55 | 8 | 35 | | 0 | D | | -22 | -1 | 22 | -12 | 10 | -1 | -6 | -12 | -23 | -38 | -37 | -23 | -20 |
1/6/16 16:20 | 1/4/16 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | S.d | -667 | 19.07 | 8 | -35 | -99 | 0 | D | | -22 | -1 | 22 | -12 | 10 | -1 | -6 | -12 | -23 | -38 | -37 | -23 | -20 |
7/6/15 16:59 | 7/1/15 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | M.d | 89 | 2.55 | 9 | 35 | | 0 | D | | | -10 | -10 | -13 | -18 | -8 | 3 | -3 | -3 | -1 | -25 | 0 | -32 |
7/6/15 16:59 | 7/1/15 | BLCM | Bellicum Pharmaceuticals, Inc | | Health | Drug | Pharmaceutical Preparations | Moseley Annemarie | TX | O | COO,EVP | S.d | -722 | 20.62 | 9 | -35 | -100 | 0 | D | | | -10 | -10 | -13 | -18 | -8 | 3 | -3 | -3 | -1 | -25 | 0 | -32 |